Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sequestosome-1 (p62) is a multifunctional scaffold/adaptor protein involved in selective autophagy and the regulation of signaling pathways such as NF-kB and Nrf2. It acts as a cargo receptor for ubiquitinated proteins, facilitating their degradation via autophagy and the ubiquitin-proteasome system. p62 also plays a role in bone remodeling and is implicated in diseases such as Paget’s disease of bone, ALS, and FTLD. Its diverse functions are mediated by multiple functional domains, including PB1, ZZ-type zinc finger, TRAF6-binding domain, LIR/KIR motifs, and UBA.
Modulation of autophagy, NF-kB and Nrf2 pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sequestosome-1 (p62).